scispace - formally typeset
B

Bharath Srinivasan

Researcher at AstraZeneca

Publications -  40
Citations -  655

Bharath Srinivasan is an academic researcher from AstraZeneca. The author has contributed to research in topics: Biology & Docking (molecular). The author has an hindex of 14, co-authored 34 publications receiving 507 citations. Previous affiliations of Bharath Srinivasan include Georgia Tech Research Institute & Instituto Gulbenkian de Ciência.

Papers
More filters
Journal ArticleDOI

Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.

TL;DR: Detailed quantitative structure-activity relationship (QSAR) analysis indicated the molecular parameters that contribute to increased potency of inhibition and would further encourage understanding in employing coumarin pyrazole hybrids as potential antibiotic agents for treating infections caused by pathogenic microbes and fungi.
Journal ArticleDOI

Elucidation of the substrate specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from Plasmodium falciparum.

TL;DR: A detailed kinetic and catalytic mechanism of the recombinant His-tagged ASL from Plasmodium falciparum shows a Uni-Bi rapid equilibrium ordered mechanism that allows the use of AICAR or its analogues as inhibitors of PfASL and hence, as novel putative anti-parasitic agents.
Journal ArticleDOI

PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity.

TL;DR: PoLi is a hybrid structure and ligand-based VS algorithm that integrates 2D fingerprint-based and 3D shape-based similarity metrics for improved virtual screening performance and Experimental validation of PoLi predictions on dihydrofolate reductase, DHFR, identifies multiple ligands with diverse molecular scaffolds, thus demonstrating the advantage of Po Li over current state-of-the-art VS methods.
Journal ArticleDOI

Synthesis of agarose-metal/semiconductor nanoparticles having superior bacteriocidal activity and their simple conversion to metal-carbon composites

TL;DR: Agarose, a naturally occurring biopolymer is used for the stabilization of metal, semiconductor nanoparticles as discussed by the authors, which shows excellent antibacterial activity against E. coli bacteria.
Journal ArticleDOI

Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.

TL;DR: This work demonstrates that the mode of binding of the inhibitor to the enzyme–NADPH binary complex conforms to the slow‐onset, tight‐binding model and provides novel insights into the role of substitutions on inhibitors of E. coli DHFR.